Free Trial

Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts

Edwards Lifesciences logo
$67.76 +1.60 (+2.42%)
(As of 09:17 AM ET)

Edwards Lifesciences Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 4Estimated
Actual EPS
(Oct. 24)
$0.67
Consensus EPS
(Oct. 24)
$0.67

Edwards Lifesciences released Q3 2024 earnings on October 24, 2024, reporting an EPS of $0.67, which met analysts' consensus estimates of $0.67. Quarterly revenue rose 8.9% year-over-year to $1.35 billion, below the consensus estimate of $1.57 billion. With a trailing EPS of $6.93 and a P/E Ratio of 9.78, Edwards Lifesciences' earnings are expected to decrease -4.28% next year, from $2.57 to $2.46 per share.

EW Upcoming Earnings

Edwards Lifesciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules.

Get Edwards Lifesciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edwards Lifesciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edwards Lifesciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.64$0.65$0.640.620 - 0.660
Q2 20243$0.70$0.70$0.700.670 - 0.710
Q3 20243$0.67$0.69$0.680.670 - 0.710
Q4 20243$0.56$0.65$0.590.530 - 0.570
FY 202412$2.57$2.69$2.61 
Q1 20253$0.59$0.60$0.59 
Q2 20253$0.62$0.63$0.63 
Q3 20253$0.59$0.64$0.61 
Q4 20253$0.63$0.64$0.64 
FY 202512$2.43$2.51$2.47 
Q1 20261$0.67$0.67$0.67 
Q2 20261$0.70$0.70$0.70 
Q3 20261$0.71$0.71$0.71 

Edwards Lifesciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/4/2025
(Estimated)
------- 
10/24/2024Q3 2024$0.67$0.67--$3.79$1.57B$1.35B    
7/24/2024Q2 2024$0.69$0.70+$0.01$0.79$1.65B$1.63B        
4/25/2024Q1 2024$0.64$0.66+$0.02$0.74$1.58B$1.60B      
2/6/2024Q4 2023$0.64$0.64-$0.67$1.50B$1.53B    
10/25/2023Q3 2023$0.59$0.59-$0.55$1.48B$1.48B        
7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51B$1.53B      
J.D. Vance: Wall Street Will Tank Bonds to Sabotage Trump (Ad)

J.D. Vance just dropped a bombshell: With Trump in office, Wall Street could drive the bond market into a death spiral—and your savings might be the first to get crushed.

4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39B$1.46B        
1/31/2023Q4 2022$0.61$0.64+$0.03$0.63$1.33B$1.35B      

Edwards Lifesciences Earnings - Frequently Asked Questions

Edwards Lifesciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on EW's earnings history.

Edwards Lifesciences updated its fourth quarter 2024 earnings guidance on Thursday, October, 24th. The company provided EPS guidance of 0.530-0.570 for the period, compared to the consensus earnings per share estimate of 0.620. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.67 earnings per share (EPS) to hit the analysts' consensus estimate of $0.67. Learn more on analysts' earnings estimate vs. EW's actual earnings.

The conference call for Edwards Lifesciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Edwards Lifesciences's latest earnings report can be read online.
Read Transcript

Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $6.31 billion.

Edwards Lifesciences (NYSE:EW) has a recorded net income of $1.40 billion. EW has generated $6.93 earnings per share over the last four quarters.

Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 9.78 and a forward price-to-earnings ratio of 26.37. The price/earnings-to-growth ratio is 3.81.

Edwards Lifesciences's earnings are expected to decrease from $2.57 per share to $2.46 per share in the next year, which is a -4.28% change.

`

More Earnings Resources from MarketBeat



This page (NYSE:EW) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners